4.7 Article

Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration

Journal

Publisher

WILEY
DOI: 10.1002/btm2.10629

Keywords

condensed MSC mass; human induced pluripotent stem cells; mesenchymal stem cells; teratomas

Ask authors/readers for more resources

In this study, we successfully isolated mesenchymal stem cells (MSCs) from a condensed mass within teratomas generated from human induced pluripotent stem cells (iPSCs). Comprehensive assessments showed that iPSC-derived MSCs (iPSC-MSCs) exhibited characteristics and cell behaviors similar to conventional MSCs, including robust proliferative capabilities and the ability to differentiate into multiple lineages. Our findings suggest that teratomas are a promising source for isolating condensed MSCs, and iPSC-MSCs derived from teratomas have the potential for tissue regeneration.
Human induced pluripotent stem cells (iPSCs) hold great promise for personalized medicine, as they can be differentiated into specific cell types, especially mesenchymal stem cells (MSCs). Therefore, our study sought to assess the feasibility of deriving MSCs from teratomas generated from human iPSCs. Teratomas serve as a model to mimic multilineage human development, thus enriching specific somatic progenitors and stem cells. Here, we discovered a small, condensed mass of MSCs within iPSC-generated teratomas. Afterward, we successfully isolated MSCs from this condensed mass, which was a byproduct of teratoma development. To evaluate the characteristics and cell behaviors of iPSC-derived MSCs (iPSC-MSCs), we conducted comprehensive assessments using qPCR, immunophenotype analysis, and cell proliferation-related assays. Remarkably, iPSC-MSCs exhibited an immunophenotype resembling that of conventional MSCs, and they displayed robust proliferative capabilities, similar to those of higher pluripotent stem cell-derived MSCs. Furthermore, iPSC-MSCs demonstrated the ability to differentiate into multiple lineages in vitro. Finally, we evaluated the therapeutic potential of iPSC-MSCs using an osteochondral defect model. Our findings demonstrated that teratomas are a promising source for the isolation of condensed MSCs. More importantly, our results suggest that iPSC-MSCs derived from teratomas possess the capacity for tissue regeneration, highlighting their promise for future therapeutic applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available